DSpace at RU >

Browsing by Author Rookus, M.A.

Full Text	Issue Date	Title	Author(s)
	2011	Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.	Cox, D.G.; Simard, J.; Sinnett, D.; Hamdi, Y.; Soucy, P., et al
	2011	Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers	Spurdle, A.B.; Marquart, L.; McGuffog, L.; Healey, S.; Sinilnikova, O., et al
	2011	Body weight and risk of breast cancer in BRCA1/2 mutation carriers	Manders, P.; Pijpe, A.; Hooning, M.J.; Kluijt, I.; Vasen, H.F., et al
	2011	Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.	Pijpe, A.; Mulder, R.L.; Manders, P.; Leeuwen, F.E. van; Rookus, M.A., et al
	2011	Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer	Maxwell, C.A.; Benitez, J.; Gomez-Baldo, L.; Osorio, A.; Bonifaci, N., et al
	2011	Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers	Antoniou, A.C.; Kartsonaki, C.; Sinilnikova, O.M.; Soucy, P.; McGuffog, L., et al
	2011	Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers	Im, K.M.; Kirchhoff, T.; Wang, X.; Green, T.; Chow, C.Y., et al
	2011	Exploring the link between MORF4L1 and risk of breast cancer.	Martrat, G.; Maxwell, C.M.; Tominaga, E.; Porta-de-la-Riva, M.; Bonifaci, N., et al
	2011	Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers	Ramus, S.J.; Kartsonaki, C.; Gayther, S.A.; Pharoah, P.D.; Sinilnikova, O.M., et al
	2010	TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.	Ruijs, M.W.; Verhoef, S.; Rookus, M.A.; Pruntel, R.; Hout, A.H. van der, et al
	2010	Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.	Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S., et al
	2010	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.	Antoniou, A.C.; Wang, X.; Fredericksen, Z.; McGuffog, L.; Tarrell, R., et al
	2010	Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers.	Pijpe, A.; Manders, P.; Mulder, R.L.; Leeuwen, F.E. van; Rookus, M.A.
	2010	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	Gaudet, M.M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J.M., et al
	2010	Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.	Antoniou, A.C.; Beesley, J.; McGuffog, L.; Sinilnikova, O.M.; Healey, S., et al
	2009	No evidence that GATA3 rs570613 SNP modifies breast cancer risk.	Johnatty, S.E.; Couch, F.J.; Fredericksen, Z.; Tarrell, R.; Spurdle, A.B., et al
	2009	Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.	Antoniou, A.C.; Sinilnikova, O.M.; McGuffog, L.; Healey, S.; Nevanlinna, H., et al
	2008	No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.	Vrieling, A.; Rookus, M.A.; Kampman, E.; Bonfrer, J.M.G.; Bosma, A., et al
	2007	No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.	Hermsen, B.B.; Olivier, R.I.; Verheijen, R.H.; Beurden, M. van; Hullu, J.A. de, et al
	2007	Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.	Vrieling, A.; Rookus, M.A.; Kampman, E.; Bonfrer, J.M.G.; Korse, C.M., et al
	2007	Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.	Chang-Claude, J.; Andrieu, N.; Rookus, M.A.; Brohet, R.M.; Antoniou, A.C., et al
	2007	Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.	Vrieling, A.; Voskuil, D.W.; Bonfrer, J.M.G.; Korse, C.M.; Doorn, J. van, et al
	2006	Decrease in mortality in Lynch syndrome families because of surveillance.	Jong, A.E. de; Hendriks, Y.M.; Kleibeuker, J.H.; Boer, S.Y. de; Cats, A., et al
	2005	The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies.	Voskuil, D.W.; Vrieling, A.; Veer, L.J. van 't; Kampman, E.; Rookus, M.A.
	2005	Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.	Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J.; Hoogerbrugge-van der Linden, N.; Verhoef, S., et al